Immuneed

Your future preclinical testing begins here

.InfoImageSection-module--image--1gb71.InfoImageSection-module--wide--3A0xd:before { opacity: 1; background-image: url('/static/5b33c34e778c4577531e9c0d236b00b1/3b8af/iStock-494156390-scaled.jpg'); }

Enabling safe & effective drugs

With strong scientific knowledge and a GLP-certified preclinical platform, we provide our customers with a tailored solution in the early stages of drug development, enabling safe and effective drugs.

.InfoImageSection-module--image--1gb71.InfoImageSection-module--wide--3A0xd.gbi--1490380518-3qR579ZsEm9rSonSAga3eP:before { opacity: 1; background-image: url('/static/189f4324251324fdc61e10ab7798b33e/22fce/2022-02-25-Immuneed-4.jpg'); }

ID.Flow

Immuneed’s specially developed platform, ID.Flow™ provides a great understanding of what happens the first time your drug meets the human immune system. Work with us to access unique technology and provide your preclinical program with comprehensive human-based data.

.InfoImageSection-module--image--1gb71.InfoImageSection-module--wide--3A0xd.gbi--1411334224-vYBNSqXth44DHnPT7Vddcn:before { opacity: 1; background-image: url('/static/4297e425802a496de732ee747bc641e9/2456e/iStock-923038872-scaled-e1621591715453.jpg'); }

Your partner in the development of future innovative therapies.

By addressing important questions related to drug safety and immunology, we cut our customers’ costs and add value to drug development projects.

Insight Hub
Could platelets block your drug’s path to success?
Platelets do far more than halt the flow of blood. So how might they interact with your drug candidate?
The spark behind Immuneed. An interview with founder Sara Mangsbo.
The spark behind Immuneed. An interview with founder Sara Mangsbo.
Unlock the potential of your complement inhibitors – by testing them wisely
Complement inhibitors – Unlock the potential by testing them wisely.
Blog
Insight